S&P 500   3,761.25 (-1.53%)
DOW   30,836.99 (-1.39%)
QQQ   302.88 (-2.03%)
AAPL   119.87 (-1.79%)
MSFT   225.80 (-0.77%)
FB   255.86 (+0.18%)
GOOGL   2,033.85 (+1.12%)
TSLA   609.98 (-6.62%)
AMZN   2,966.15 (-1.29%)
NVDA   490.01 (-4.33%)
BABA   230.24 (-2.55%)
CGC   30.94 (-6.92%)
GE   13.35 (-0.67%)
MU   83.16 (-6.68%)
NIO   38.91 (-6.31%)
AMD   77.23 (-4.49%)
T   28.95 (+0.80%)
F   11.79 (-3.12%)
ACB   9.71 (-7.17%)
DIS   186.38 (-3.06%)
BA   222.24 (-2.77%)
NFLX   510.50 (-1.96%)
PFE   34.17 (-0.64%)
S&P 500   3,761.25 (-1.53%)
DOW   30,836.99 (-1.39%)
QQQ   302.88 (-2.03%)
AAPL   119.87 (-1.79%)
MSFT   225.80 (-0.77%)
FB   255.86 (+0.18%)
GOOGL   2,033.85 (+1.12%)
TSLA   609.98 (-6.62%)
AMZN   2,966.15 (-1.29%)
NVDA   490.01 (-4.33%)
BABA   230.24 (-2.55%)
CGC   30.94 (-6.92%)
GE   13.35 (-0.67%)
MU   83.16 (-6.68%)
NIO   38.91 (-6.31%)
AMD   77.23 (-4.49%)
T   28.95 (+0.80%)
F   11.79 (-3.12%)
ACB   9.71 (-7.17%)
DIS   186.38 (-3.06%)
BA   222.24 (-2.77%)
NFLX   510.50 (-1.96%)
PFE   34.17 (-0.64%)
S&P 500   3,761.25 (-1.53%)
DOW   30,836.99 (-1.39%)
QQQ   302.88 (-2.03%)
AAPL   119.87 (-1.79%)
MSFT   225.80 (-0.77%)
FB   255.86 (+0.18%)
GOOGL   2,033.85 (+1.12%)
TSLA   609.98 (-6.62%)
AMZN   2,966.15 (-1.29%)
NVDA   490.01 (-4.33%)
BABA   230.24 (-2.55%)
CGC   30.94 (-6.92%)
GE   13.35 (-0.67%)
MU   83.16 (-6.68%)
NIO   38.91 (-6.31%)
AMD   77.23 (-4.49%)
T   28.95 (+0.80%)
F   11.79 (-3.12%)
ACB   9.71 (-7.17%)
DIS   186.38 (-3.06%)
BA   222.24 (-2.77%)
NFLX   510.50 (-1.96%)
PFE   34.17 (-0.64%)
S&P 500   3,761.25 (-1.53%)
DOW   30,836.99 (-1.39%)
QQQ   302.88 (-2.03%)
AAPL   119.87 (-1.79%)
MSFT   225.80 (-0.77%)
FB   255.86 (+0.18%)
GOOGL   2,033.85 (+1.12%)
TSLA   609.98 (-6.62%)
AMZN   2,966.15 (-1.29%)
NVDA   490.01 (-4.33%)
BABA   230.24 (-2.55%)
CGC   30.94 (-6.92%)
GE   13.35 (-0.67%)
MU   83.16 (-6.68%)
NIO   38.91 (-6.31%)
AMD   77.23 (-4.49%)
T   28.95 (+0.80%)
F   11.79 (-3.12%)
ACB   9.71 (-7.17%)
DIS   186.38 (-3.06%)
BA   222.24 (-2.77%)
NFLX   510.50 (-1.96%)
PFE   34.17 (-0.64%)
Log in
ETR:HNL

Dr. Hönle Stock Forecast, Price & News

€47.40
+0.85 (+1.83 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
€45.90
Now: €47.40
€47.65
50-Day Range
€44.35
MA: €52.06
€56.30
52-Week Range
€24.45
Now: €47.40
€60.40
Volume7,868 shs
Average VolumeN/A
Market Capitalization$287.33 million
P/E Ratio56.23
Dividend Yield1.09%
BetaN/A
Dr. Hönle AG operates in the UV market worldwide. It operates through three segments: Equipment & Systems, Glass & Lamps, and Adhesives. The Equipment & Systems segment offers UV equipment and systems, LED-UV units, IR units, inert systems, disinfection systems, solar simulation systems and light fixtures, lighting systems, UV measuring technology products, UV-adhesives, and components and replacement parts. This segment also provides hot air systems, and powder spraying and extraction systems for sheet-fed offset printing; UV dryers for Web printing; UV systems with nitrogen inertisation; and drying systems. Its products are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Glass & Lamps segment offers UV low and medium pressure lamps; infrared emitters; electronic power supplies; UV sensors and measuring technology products; UV measuring devices; and submersible and immersion tube systems, as well as accessories. This segment also provides UV bulbs; and quartz glass tubing and rods for the lamp, automotive, semiconductor, and fiber cable industries. The Adhesives segment offers industrial, UV, medical grade, and conductive adhesives; dosing systems; potting and sealing compounds; and UV curing units. Dr. Hönle AG was founded in 1976 and is headquartered in Gräfelfing, Germany.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Electronic Components
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone49 89 85608 0
Employees647
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$95.09 million
Cash Flow€5.80 per share
Book Value€19.44 per share

Profitability

Miscellaneous

Market Cap$287.33 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

1.49 out of 5 stars

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
€47.40
+0.85 (+1.83 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HNL News and Ratings via Email

Sign-up to receive the latest news and ratings for HNL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Dr. Hönle (ETR:HNL) Frequently Asked Questions

Is Dr. Hönle a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dr. Hönle in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Dr. Hönle stock.
View analyst ratings for Dr. Hönle
or view top-rated stocks.

What stocks does MarketBeat like better than Dr. Hönle?

Wall Street analysts have given Dr. Hönle a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Dr. Hönle wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Dr. Hönle's stock price been impacted by Coronavirus (COVID-19)?

Dr. Hönle's stock was trading at €34.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HNL shares have increased by 37.8% and is now trading at €47.40.
View which stocks have been most impacted by COVID-19
.

Is Dr. Hönle a good dividend stock?

Dr. Hönle pays an annual dividend of €0.50 per share and currently has a dividend yield of 1.09%. The dividend payout ratio of Dr. Hönle is 59.31%. This payout ratio is at a healthy, sustainable level, below 75%.
View Dr. Hönle's dividend history.

What price target have analysts set for HNL?

2 equities research analysts have issued 12 month target prices for Dr. Hönle's stock. Their forecasts range from €65.00 to €68.50. On average, they anticipate Dr. Hönle's stock price to reach €66.75 in the next twelve months. This suggests a possible upside of 40.8% from the stock's current price.
View analysts' price targets for Dr. Hönle
or view top-rated stocks among Wall Street analysts.

Who are Dr. Hönle's key executives?

Dr. Hönle's management team includes the following people:
  • Dr. Norbert Haimerl M.B.A., CFO. MD of IT, HR & Investor Relations and Member of Management Board (Age 59, Pay $898k)
  • Mr. Heiko Runge Grad. Eng., MD of Sales & Marketing and Member of Management Board (Age 57, Pay $866k)
  • Mr. Rainer Pumpe, MD of Devel. & Production and Member of the Management Board
  • Peter Weinert, Head of Investor Relations

Who are some of Dr. Hönle's key competitors?

What is Dr. Hönle's stock symbol?

Dr. Hönle trades on the ETR under the ticker symbol "HNL."

What is Dr. Hönle's stock price today?

One share of HNL stock can currently be purchased for approximately €47.40.

How much money does Dr. Hönle make?

Dr. Hönle has a market capitalization of $287.33 million and generates $95.09 million in revenue each year.

How many employees does Dr. Hönle have?

Dr. Hönle employs 647 workers across the globe.

What is Dr. Hönle's official website?

The official website for Dr. Hönle is www.hoenle.de.

How can I contact Dr. Hönle?

The company can be reached via phone at 49 89 85608 0.


This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.